Latest news

All.Can International is currently looking to recruit a Chief Executive Officer (CEO) to lead the initiative into an exciting new phase.

At the 4th Biennial World Summit of Brain Tumour Patient Advocates Suzanne Wait, shared findings from the All.Can patient survey with participants, focusing on findings specific to patients with brain/central nervous system (CNS) tumours.

On 2 October 2019 All.Can international sent a letter to Stella Kyriakidou welcoming her unique perspective in the field of health, and sharing key findings from the All.Can patient survey.

The Canadian All.Can cancer initiative has this month published a major report of cancer care recommendations based on patient insights following a Canada-wide patient survey conducted last year that gathered…

All.Can is delighted to welcome Roche as a new funding member of the international initiative.

All.Can Australia has launched the results of the national-level findings from the All.Can international patient survey. 

It is with great regret that All.Can has decided to discontinue the ICHOM–All.Can Improving Value in Cancer Care project.

All.Can Italy held its first public seminar in Rome, bringing together patients, key opinion leaders and policymakers

Based on results of the All.Can patient survey, which was completed by almost 4,000 people affected by different cancers across 10 countries.